In a new job - September 15, 2021
Nordic Nanovector appoints new CEO
Nordic Nanovector has appointed Erik Skullerud as Chief Executive Officer (CEO). Erik Skullerud will take up the position on 20 September 2021 and will be based in the company’s office in Zug, Switzerland, splitting his time between Zug and Nordic Nanovector’s head office in Oslo. “I am very pleased that Erik has agreed to join […]
In a new job - September 10, 2021
BerGenBio announces leadership changes
BerGenBio has announced the appointment of Martin Olin as new Chief Executive Officer from 8 September 2021. Following twelve years as CEO of BerGenBio, Richard Godfrey has decided to step down as CEO of the company with immediate effect to pursue other business interests. “I have thoroughly enjoyed my past twelve years at BerGenBio and […]
In a new job - September 8, 2021
He is the new CFO of Anocca
Anocca has announced the appointment of Jacob Michlewicz as Chief Financial Officer, effective immediately, and based at the company’s headquarters in Sweden. “We’re delighted for Jacob to join us as CFO, following swiftly on from our recent Series B financing, which took us to well over $100m (SEK 900 million) raised since our founding. Jacob’s […]
In a new job - September 7, 2021
SmiLe recruits new business coach in pharma/biotech
SmiLe has appointed Charlotte Leife as new business coach, thereby strengthening its expertise in the international pharma and biotech industry. “I am very happy to be able to welcome Charlotte to SmiLe. With Charlotte we bring in another senior business coach to complement the team with extensive, international industry expertise in pharma and biotech. With […]
In a new job - September 5, 2021
XNK Therapeutics appoints new Chief Business Officer
XNK Therapeutics has announced the appointment of Markus Thor as Chief Business Officer. Thor will be member of the company’s management team. “Markus is a welcome addition to the XNK team,” says Johan Liwing, CEO of XNK Therapeutics. “Markus has an extensive business development background which will be incredibly useful to XNK as the company […]
In a new job - September 3, 2021
He is the new CMO of Cyxone
Cyxone has announced that Cornel Pater has been appointed as the company’s new Chief Medical Officer (CMO). Most recently, he held the position as Global Medical Director of Clinical Development at Novartis Pharma. As CMO, Cornel Pater is part of Cyxone’s executive management and will play an important role in the continued development of the […]
